Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ)
CNY 3.87
(0.0%)
CNY 3.87
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.82 Billion CNY | 31.9% |
| 2022 | 2.89 Billion CNY | 14.56% |
| 2021 | 2.52 Billion CNY | -18.74% |
| 2020 | 3.11 Billion CNY | 6.86% |
| 2019 | 2.91 Billion CNY | 41.98% |
| 2018 | 2.05 Billion CNY | 51.35% |
| 2017 | 1.35 Billion CNY | 15.79% |
| 2016 | 1.17 Billion CNY | 0.87% |
| 2015 | 1.16 Billion CNY | -4.66% |
| 2014 | 1.21 Billion CNY | -9.95% |
| 2013 | 1.35 Billion CNY | 12.89% |
| 2012 | 1.19 Billion CNY | 11.04% |
| 2011 | 1.07 Billion CNY | 13.22% |
| 2010 | 952.49 Million CNY | 113.81% |
| 2009 | 445.48 Million CNY | 38.9% |
| 2008 | 320.71 Million CNY | 1.54% |
| 2007 | 315.86 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 3.65 Billion CNY | -7.63% |
| 2024 Q1 | 4.3 Billion CNY | 12.52% |
| 2024 Q2 | 3.96 Billion CNY | -7.88% |
| 2023 Q2 | 3.15 Billion CNY | 1.9% |
| 2023 Q3 | 3.1 Billion CNY | -1.51% |
| 2023 FY | 3.82 Billion CNY | 31.9% |
| 2023 Q4 | 3.82 Billion CNY | 22.95% |
| 2023 Q1 | 3.09 Billion CNY | 6.89% |
| 2022 Q2 | 2.52 Billion CNY | 4.9% |
| 2022 Q1 | 2.4 Billion CNY | -4.75% |
| 2022 FY | 2.89 Billion CNY | 14.56% |
| 2022 Q4 | 2.89 Billion CNY | 11.26% |
| 2022 Q3 | 2.6 Billion CNY | 3.06% |
| 2021 Q3 | 2.64 Billion CNY | 1.94% |
| 2021 Q2 | 2.59 Billion CNY | -0.98% |
| 2021 Q1 | 2.61 Billion CNY | -15.87% |
| 2021 Q4 | 2.52 Billion CNY | -4.32% |
| 2021 FY | 2.52 Billion CNY | -18.74% |
| 2020 Q2 | 2.81 Billion CNY | -6.47% |
| 2020 Q4 | 3.11 Billion CNY | 0.17% |
| 2020 Q1 | 3 Billion CNY | 3.2% |
| 2020 FY | 3.11 Billion CNY | 6.86% |
| 2020 Q3 | 3.1 Billion CNY | 10.52% |
| 2019 Q2 | 2.7 Billion CNY | 5.57% |
| 2019 FY | 2.91 Billion CNY | 41.98% |
| 2019 Q4 | 2.91 Billion CNY | 7.41% |
| 2019 Q3 | 2.71 Billion CNY | 0.21% |
| 2019 Q1 | 2.56 Billion CNY | 24.95% |
| 2018 Q4 | 2.05 Billion CNY | 38.81% |
| 2018 Q1 | 1.3 Billion CNY | -3.98% |
| 2018 FY | 2.05 Billion CNY | 51.35% |
| 2018 Q2 | 1.36 Billion CNY | 5.16% |
| 2018 Q3 | 1.47 Billion CNY | 7.99% |
| 2017 Q1 | 1.16 Billion CNY | -0.74% |
| 2017 FY | 1.35 Billion CNY | 15.79% |
| 2017 Q4 | 1.35 Billion CNY | 17.11% |
| 2017 Q3 | 1.15 Billion CNY | -3.53% |
| 2017 Q2 | 1.19 Billion CNY | 3.26% |
| 2016 FY | 1.17 Billion CNY | 0.87% |
| 2016 Q4 | 1.17 Billion CNY | 4.41% |
| 2016 Q3 | 1.12 Billion CNY | 2.29% |
| 2016 Q1 | 1.09 Billion CNY | -5.51% |
| 2016 Q2 | 1.09 Billion CNY | -0.04% |
| 2015 Q3 | 1.06 Billion CNY | -2.32% |
| 2015 Q1 | 1.1 Billion CNY | -8.84% |
| 2015 Q4 | 1.16 Billion CNY | 8.63% |
| 2015 FY | 1.16 Billion CNY | -4.66% |
| 2015 Q2 | 1.09 Billion CNY | -1.43% |
| 2014 FY | 1.21 Billion CNY | -9.95% |
| 2014 Q3 | 1.13 Billion CNY | -7.26% |
| 2014 Q1 | 1.14 Billion CNY | -15.47% |
| 2014 Q4 | 1.21 Billion CNY | 6.83% |
| 2014 Q2 | 1.22 Billion CNY | 7.53% |
| 2013 Q4 | 1.35 Billion CNY | 14.91% |
| 2013 Q3 | 1.17 Billion CNY | -1.75% |
| 2013 Q2 | 1.19 Billion CNY | 2.06% |
| 2013 FY | 1.35 Billion CNY | 12.89% |
| 2013 Q1 | 1.17 Billion CNY | -2.03% |
| 2012 Q2 | 1.04 Billion CNY | -3.44% |
| 2012 FY | 1.19 Billion CNY | 11.04% |
| 2012 Q4 | 1.19 Billion CNY | 5.24% |
| 2012 Q3 | 1.13 Billion CNY | 8.74% |
| 2012 Q1 | 1.08 Billion CNY | 0.48% |
| 2011 Q4 | 1.07 Billion CNY | 11.15% |
| 2011 Q3 | 970.22 Million CNY | -7.8% |
| 2011 Q2 | 1.05 Billion CNY | 1.96% |
| 2011 Q1 | 1.03 Billion CNY | 8.36% |
| 2011 FY | 1.07 Billion CNY | 13.22% |
| 2010 Q3 | 611.77 Million CNY | 9.83% |
| 2010 Q1 | 540.69 Million CNY | 21.37% |
| 2010 Q2 | 557.03 Million CNY | 3.02% |
| 2010 FY | 952.49 Million CNY | 113.81% |
| 2010 Q4 | 952.49 Million CNY | 55.69% |
| 2009 FY | 445.48 Million CNY | 38.9% |
| 2009 Q4 | 445.48 Million CNY | 0.0% |
| 2008 FY | 320.71 Million CNY | 1.54% |
| 2007 FY | 315.86 Million CNY | 0.0% |